Category: Autoimmune
Global Autoimmune
-
Global In-vitro Diagnostics Market Assessment, By Product Type [Instruments, Reagents and Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation and Hemostasis, Urinalysis, Others], By Settings [Laboratories, Point-of-Care], By Application [Infectious Diseases, Diabetes, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F
... [Infectious Diseases, Diabetes, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F Global In-vitro diagnostics market is projected to ... Read More
-
Biologics Market Assessment, By Product [Monoclonal Antibodies, Recombinant Hormones/Proteins, Vaccines, Cellular Based Biologics, Gene-Based Biologics, Therapeutic Enzymes, Others] By Application [Infectious Diseases, Cancer, Autoimmune Diseases, Cardiovascular, Hematological Disorders, Others] By Drug Classification [Branded Drugs, Generic Drugs], By Mode of Purchase [Prescription Drugs, Over-the-counter Drugs] By Distribution Channel [Hospital Pharmacies, Retail Pharmacies, Online Pharmacies] By Region, Opportunities and Forecast, 2017-2031F
... Drugs], By Mode of Purchase [Prescription Drugs, Over-the-counter Drugs] By Distribution Channel [Hospital Pharmacies, Retail Pharmacies, Online Pharmacies] By Region, Opportunities and Forecast, 2017-2031F Global biologics market size was valued at USD 401.34 billion in ... Read More
-
Autoimmune Disease Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis
... according to Renub Research. Autoimmune diseases are diverse situations wherein the immune system mistakenly attacks the body's cells, tissues, and organs. These outcomes result in irritation and harm, causing various symptoms. Over 80 diagnosed autoimmune ... Read More
-
Systemic Lupus Erythematosus (SLE) Drugs Market by Drug Class (Antimalarials Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Cytotoxic and Immunosuppressive Drugs, Biologics, and Others), Mode of Delivery (Intravenous, Subcutaneous, Oral), and Region 2024-2032
... erythematosus (SLE) drugs market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.83% during 2024-2032.The increasing ... Read More
-
Global Lupus Nephritis Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... of the Lupus Nephritis industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Lupus Nephritis. The report also introduces players in the industry ... Read More
-
Immunotherapy Drugs Market (Drug Type: Monoclonal Antibodies, Immunomodulators, Cell Therapy and Others; and Therapy Area: Cancer, Autoimmune Diseases, Infectious Diseases, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Market – Scope of Report TMR’s report on the global immunotherapy drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
IVD & LDT For Autoimmune Diseases Market by Technology (Clinical Chemistry, Coagulation, Hematology), Application (Addison’s Disease, Alopecia Areata, Ankylosing Spondylitis) - Global Forecast 2024-2030
... at USD 17.27 billion in 2023 and expected to reach USD 18.30 billion in 2024, at a CAGR 5.22% to reach USD 24.68 billion by 2030. Global IVD & LDT For Autoimmune Diseases Market FPNV ... Read More
-
Autoimmune Disease Diagnostics Market by Type (Localized Autoimmune Disease Diagnostics, Systemic Autoimmune Disease Diagnostics), Indication (Addison Disease, Celiac Disease, Dermatomyositis), Test, Product, End User - Global Forecast 2024-2030
... estimated at USD 5.08 billion in 2023 and expected to reach USD 5.53 billion in 2024, at a CAGR 9.06% to reach USD 9.33 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Bioengineered Protein Drugs Market by Drug Type (Monoclonal Antibodies, Therapeutic Proteins, Vaccines), Disease (Arthritis, Autoimmune Disorders, Blood Disorders), End-User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 415.13 billion in 2024, at a CAGR 7.76% to reach USD 653.35 billion by 2030. Global Bioengineered Protein Drugs Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Autoimmune Disease Drugs Market by Indication (Diabetes Mellitus Type 1, Multiple Sclerosis, Rare Diseases), Drug Class (Anti-Inflammatory, Antihyperglycemic, Immunosuppressants), Distribution - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 116.79 billion in 2024, at a CAGR 7.52% to reach USD 180.67 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Systemic Lupus Erythematosus Market by Drug Type (Antimalarial Drugs, B-Cell Modulators, Biologics), Mode of Delivery (Intravenous, Oral, Subcutaneous) - Global Forecast 2024-2030
... 2023 and expected to reach USD 2.24 billion in 2024, at a CAGR 10.54% to reach USD 4.12 billion by 2030. Global Systemic Lupus Erythematosus Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Biologics Market by Product (Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies), Indication (Autoimmune Diseases, Cancer, Infectious Diseases), End-user - Global Forecast 2024-2030
... and expected to reach USD 302.68 billion in 2024, at a CAGR 5.39% to reach USD 415.18 billion by 2030. Global Biologics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Biosimilars Market by Product (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Indication (Autoimmune Diseases, Blood Disorders, Chronic Diseases), Manufacturing - Global Forecast 2024-2030
... 2023 and expected to reach USD 49.91 billion in 2024, at a CAGR 23.31% to reach USD 176.48 billion by 2030. Global Biosimilars Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Auto-disable Syringes Market by Indication (Infectious Diseases, Inflammatory/Auto-Immune Diseases), Application (Blood Collection, Drug Delivery, Vaccination), End-User - Global Forecast 2024-2030
... to reach USD 25.94 billion in 2024, at a CAGR 11.54% to reach USD 50.01 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Auto-disable Syringes Market. It offers ... Read More
-
Systemic Lupus Erythematosus Treatment Global Market Report 2024
... Online SalesCovering: GlaxoSmithKline plc; Aurinia Pharmaceuticals Inc.; Pfizer Inc.; Merck & Co Inc.; Anthera Pharmaceuticals Inc. Systemic Lupus Erythematosus Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management ... Read More
-
Global Immunoassay Market Size study & Forecast, by Product (Reagents & Kits, Analyzers/Instruments, Software & Services), by Technology (Radioimmunoassay (RIA), Enzyme Immunoassays (EIA) Rapid Test, Others), by End-use (Therapeutic Drug, Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases), by Application (Hospitals, Blood Banks, Clinical Laboratories, Others), by Form (Natural Immunoassay, Synthetic Immunoassay) and Regional Analysis, 2023-2030
... Disease Testing, Autoimmune Diseases), by Application (Hospitals, Blood Banks, Clinical Laboratories, Others), by Form (Natural Immunoassay, Synthetic Immunoassay) and Regional Analysis, 2023-2030 Global Immunoassay Market is valued at approximately USD XX billion in 2022 and ... Read More
-
Systemic Lupus Erythematosus Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
... the retail pharmacy and online pharmacy markets. The global systemic lupus erythematosus treatment market is expected to reach an estimated $4.6 billion by 2030 with a CAGR of 9.1% from 2024 to 2030. The major ... Read More
-
Global Immune Thrombocytopenia Drug Market (2024 Edition): Analysis By Treatment (Intravenous Immunoglobulins, Thrombopoietin Receptor Agonists, Corticosteroids, Others), By Type, By End-User, By Region: Market Insights and Forecast (2019-2029)
... research report titled “Global Immune Thrombocytopenia Drug Market (2024 Edition)” which provides a complete analysis of the Global Immune Thrombocytopenia Drug industry in terms of market segmentation By Treatment (Intravenous Immunoglobulins, Thrombopoietin Receptor Agonists, Corticosteroids, ... Read More
-
2024 Global Autoimmune Disease Treatment Market Industry (2030 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include ... Read More
-
Myasthenia Gravis Disease Treatment Market Forecasts to 2030 – Global Analysis By Type (Generalized Myasthenia Gravis, Ocular Myasthenia Gravis, Transient Neonatal Myasthenia Gravis and Other Types), Drug Class (Cholinesterase Inhibitors, Monoclonal Antibodies, Corticosteroids, Immunosuppressants, Intravenous Immunoglobulins and Other Drug Classes), Treatment Modality, Distribution Channel and By Geography
... Immunoglobulins and Other Drug Classes), Treatment Modality, Distribution Channel and By Geography According to Stratistics MRC, the Global Myasthenia Gravis Treatment Market is accounted for $2.2 billion in 2023 and is expected to reach $3.9 ... Read More
-
Biomarker Discovery Outsourcing Services Market Share, Size, Trends, Industry Analysis Report, By Type; By Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases, Others); By Discovery Phase; By End-use; By Region, And Segment Forecasts, 2023 - 2032
... The global biomarker discovery outsourcing services market size is expected to reach USD 70.44 billion by 2032, according to a new study by Polaris Market Research. The report “Biomarker Discovery Outsourcing Services Market Share, Size, ... Read More
-
2024 Global: Autoimmune Disease Treatment Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
Global Injection Pen Market: Analysis By Type (Disposable Injection Pen and Reusable Injection Pen), By Therapy (Diabetes Therapy, Growth Hormone Therapy, Fertility Therapy, Autoimmune Diseases Therapy, Cancer Therapy & Others), By End User (Hospitals & Clinics, Home Care & Others), By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2028
... Clinics, Home Care & Others), By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2028 The global injection pen market in 2022 was valued at US$39.10 billion. The market is ... Read More
-
Autoimmune Disease Diagnostics: Global Markets
... and region. Report Includes: 41 data tables and 30 additional tables An overview of the global market landscape related to the autoimmune disease diagnostics In-depth analysis of global market trends, featuring historical revenue data for ... Read More
-
Stem Cell Therapy Market by Type (Allogeneic, Autologous), Cell Source (Adipose Tissue, Bone Marrow, Placenta/Umbilical Cord), Therapeutic Application (Musculoskeletal, Wounds, Surgeries, Inflammatory, Autoimmune, Cardiovascular) - Global Forecast to 2028
... is projected to reach USD 615 million by 2028 from USD 286 million in 2023, at a CAGR of 16.5% during the forecast period. Key market players are focusing on developing new stem cell therapies ... Read More
Research Assistance
